Skip to main content

A Framework for Automated Quality Assurance and Documentation for Pharma 4.0

  • Conference paper
  • First Online:
Computer Safety, Reliability, and Security (SAFECOMP 2021)

Abstract

The production sector is experiencing significant transformations driven by comprehensive digitalization, interconnection, and further automation advances. One sub-sector that can benefit significantly from these trends is the production of Advanced Therapy Medicinal Products (ATMPs). ATMPs show promise for treating different serious conditions, but they are very expensive—being patient tailored products whose production is a highly manual, minimally automated process. In a recent research project with an ATMP producer, we investigated how the degree of automation can be increased. It became apparent that in parallel to increasing automation across the actual production steps, quality assurance needs to be addressed in a similar way. This paper introduces a framework for automating (parts of) the quality assurance of ATMPs using two concepts: (a) digital shadows or twins and (b) assurance cases. We demonstrate its conceptual implementation along a case study for Car-T cell products used to treat certain forms of cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Details of the asset administration shell - part 1. https://www.plattform-i40.de/PI40/Redaktion/DE/Downloads/Publikation/Details_of_the_Asset_Administration_Shell_Part1_V3.html

  2. The development of a digital plant maturity model to aid transformation in biopharmaceutical manufacturing. https://pharmaceutical.report/whitepapers/the-development-of-a-digital-plant-maturity-model-to-aid-transformation-in-biopharmaceutical-manufacturing/1848

  3. EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 - Part 4 - Guidelines on Good Manufacturing Practice specific to Advanced Therapy Medicinal Products. https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-4/2017_11_22_guidelines_gmp_for_atmps.pdf

  4. Submodel templates of the asset administration shell - zvei digital nameplate for industrial equipment (version 1.0). https://www.plattform-i40.de/PI40/Redaktion/DE/Downloads/Publikation/Submodel_Templates-Asset_Administration_Shell-digital_nameplate.html

  5. Bedenbender, H., et al.: Examples of the Asset Administration Shell for I4.0 Components. ZVEI White Paper (2017)

    Google Scholar 

  6. Chowdhury, T., Wassyng, A., Paige, R.F., Lawford, M.: Systematic evaluation of (safety) assurance cases. In: Casimiro, A., Ortmeier, F., Bitsch, F., Ferreira, P. (eds.) SAFECOMP 2020. LNCS, vol. 12234, pp. 18–33. Springer, Cham (2020). https://doi.org/10.1007/978-3-030-54549-9_2

    Chapter  Google Scholar 

  7. Grangel-González, I., Halilaj, L., Coskun, G., Auer, S., Collarana, D., Hoffmeister, M.: Towards a semantic administrative shell for industry 4.0 components. In: IEEE 10th Intlernation Conference on Semantic Computing (ICSC), pp. 230–237 (2016)

    Google Scholar 

  8. Holtmann, J., Steghöfer, J.P., Rath, M., Schmelter, D.: Cutting through the jungle: disambiguating model-based traceability terminology. In: IEEE 28th International Requirements Engineering Conference (RE), pp. 8–19 (2020)

    Google Scholar 

  9. Li, Y., Huo, Y., Yu, L., Wang, J.: Quality control and nonclinical research on car-t cell products: general principles and key issues. Engineering 5(1), 122–131 (2019)

    Article  Google Scholar 

  10. Marshall, S., et al.: Model-informed drug discovery and development: current industry good practice and regulatory expectations and future perspectives. CPT Pharma. Syst. Pharmacol. 8(2), 87–96 (2019)

    Google Scholar 

  11. Mould, D.R., Upton, R.: Basic concepts in population modeling, simulation, and model-based drug development. CPT Pharma. Syst. Pharmacol. 1(9), 1–14 (2012)

    Google Scholar 

  12. Reich, J., Zeller, M., Schneider, D.: Automated evidence analysis of safety arguments using digital dependability identities. In: Romanovsky, A., Troubitsyna, E., Bitsch, F. (eds.) SAFECOMP 2019. LNCS, vol. 11698, pp. 254–268. Springer, Cham (2019). https://doi.org/10.1007/978-3-030-26601-1_18

    Chapter  Google Scholar 

  13. Schneider, D., Trapp, M., Papadopoulos, Y., Armengaud, E., Zeller, M., Höfig, K.: Wap: digital dependability identities. In: 2015 IEEE 26th International Symposium on Software Reliability Engineering (ISSRE), pp. 324–329. IEEE (2015)

    Google Scholar 

  14. Spriggs, J.: GSN-the Goal Structuring Notation: A Structured Approach to Presenting Arguments. Springer Science & Business Media, London (2012)

    Google Scholar 

  15. Stembridge, K., Adkins, M.: Making the move to electronic batch records. Pharma. Technol. 42(4), 52–55 (2018)

    Google Scholar 

  16. Terzimehic, T., et al.: Towards an industry 4.0 compliant control software architecture using IEC 61499 & opc ua. In: 22nd IEEE Intl. Conference on Emerging Technologies and Factory Automation (ETFA), pp. 1–4 (2017)

    Google Scholar 

  17. Tyagarajan, S., Spencer, T., Smith, J.: Optimizing car-t cell manufacturing processes during pivotal clinical trials. Mol. Therapy Methods Clin. Dev. 16, 136–144 (2020)

    Article  Google Scholar 

  18. Vormittag, P., Gunn, R., Ghorashian, S., Veraitch, F.S.: A guide to manufacturing car t cell therapies. Curr. Opin. Biotechnol. 53, 164–181 (2018)

    Article  Google Scholar 

  19. Wagner, C., et al.: The role of the industry 4.0 asset administration shell and the digital twin during the life cycle of a plant. In: 22nd IEEE International Conference on Emerging Technologies and Factory Automation (ETFA), pp. 1–8 (2017)

    Google Scholar 

  20. Zhang, Y., Larson, B., Hatcliff, J.: Assurance case considerations for interoperable medical systems. In: Gallina, B., Skavhaug, A., Schoitsch, E., Bitsch, F. (eds.) SAFECOMP 2018. LNCS, vol. 11094, pp. 42–48. Springer, Cham (2018). https://doi.org/10.1007/978-3-319-99229-7_5

    Chapter  Google Scholar 

  21. Zobel-Roos, S., et al.: Accelerating biologics manufacturing by modeling or: is approval under the GBD and pat approaches demanded by authorities acceptable without a digital-twin? Processes 7(2), 94 (2019)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel Schneider .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Schmidt, A. et al. (2021). A Framework for Automated Quality Assurance and Documentation for Pharma 4.0. In: Habli, I., Sujan, M., Bitsch, F. (eds) Computer Safety, Reliability, and Security. SAFECOMP 2021. Lecture Notes in Computer Science(), vol 12852. Springer, Cham. https://doi.org/10.1007/978-3-030-83903-1_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-83903-1_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-83902-4

  • Online ISBN: 978-3-030-83903-1

  • eBook Packages: Computer ScienceComputer Science (R0)

Publish with us

Policies and ethics